Bank of America’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-610
Closed -$1K 7413
2017
Q1
$1K Hold
610
﹤0.01% 6917
2016
Q4
$1K Hold
610
﹤0.01% 6970
2016
Q3
$2K Sell
610
-25
-4% -$54 ﹤0.01% 6888
2016
Q2
$1K Buy
635
+560
+747% +$1.35K ﹤0.01% 7061
2016
Q1
$0 Sell
75
-1
-1% -$2 ﹤0.01% 7601
2015
Q4
$0 Hold
76
﹤0.01% 7618
2015
Q3
$0 Sell
76
-5
-6% -$33 ﹤0.01% 7619
2015
Q2
$1K Buy
81
+31
+62% +$435 ﹤0.01% 7185
2015
Q1
$1K Sell
50
-140
-74% -$2.76K ﹤0.01% 6936
2014
Q4
$3K Sell
190
-213
-53% -$4.68K ﹤0.01% 7442
2014
Q3
$10K Buy
403
+357
+776% +$8.62K ﹤0.01% 7348
2014
Q2
$1K Sell
46
-286
-86% -$7.31K ﹤0.01% 7953
2014
Q1
$10K Sell
332
-979
-75% -$32.9K ﹤0.01% 7199
2013
Q4
$41K Buy
1,311
+1,265
+2,750% +$39.6K ﹤0.01% 6682
2013
Q3
$1K Sell
46
-7,662
-99% -$186K ﹤0.01% 7789
2013
Q2
$164K Buy
+7,708
New +$190K ﹤0.01% 5811

Other funds holding WINT

Bank of America's WINT Position: Q2 2017 in Review

Bank of America sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 610 shares — an estimated $1K sold.

Bank of America first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $164K in Q2 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Bank of America reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Bank of America sold 610 Windtree Therapeutics Inc shares in Q2 2017, an estimated $1K.
  • Bank of America first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Bank of America's Windtree Therapeutics Inc position peaked at $164K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Bank of America's 13F filing for Q2 2017, filed 14 Aug 2017.